Exaggerating or falsifying Clinical trials is considered FDA fraud

Falsifying or exaggerating clinical trial results be deemed FDA fraud :

The FDA relies on trial data to verify the safety and efficacy of drugs. If any party in the trial process misrepresents, omits, or falsifies the data, such FDA fraud can create far-reaching damage to future users of the drug. Healthcare employers and healthcare whistleblowers are on the lookout for falsification of trial data that increase revenue dollars for the provider. 

For Personalized Attention Of Legal Counsel


Available by Appointment
Free Initial Review and Consultation

If you are a physician, nurse, dentist, pharmacist, hospital, physician group, or medical lab looking for legal advice then you’ve reached the right site. Today’s healthcare environment is riddled with complex issues of professionalism, market strategy, and the law. Contact us now!

Menu